Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Fetal Specific Gene LIN28B Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia

Rebecca E Ling, Thomas Jackson, Natalina Elliott, Joe W Cross, Lucy Hamer, Arundhati S Wuppalapati, Alastair L Smith, Catherine M Chahrour, Okan Sevim, Deena Iskander, Guanlin Wang, Sorcha I O'Byrne, Siobhan Rice, Joe R Harman, Bethan Psaila, Rhys G Morgan, Irene Roberts, Thomas A Milne, Anindita Roy

Blood (2024) 144 (Supplement 1): 199.

https://doi.org/10.1182/blood-2024-198819

Published: 2024

Journal Articles

The IRF2BP2-RARα Fusion Generated By a Cryptic Rearrangement Transforms Hematopoietic Stem/Progenitor Cells and Induces Retinoid Sensitive Acute Promyelocytic Leukemia (APL)

Jelena V Jovanovic, M Carmen Chillón, Christelle Vincent-Fabert, Richard Dillon, Edwige Voisset, Norma C Gutiérrez, Ellen Solomon, Ramón García Sanz, Ana A. Martin Lopez, Yvonne G Morgan, Jennie Lok, Estelle Duprez, PhD, Marcos González Díaz, David Grimwade

Blood (2014) 124 (21): 2325.

https://doi.org/10.1182/blood.V124.21.2325.2325

Published: 2014

Journal Articles

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Charlotte G Nyvold, M.Sci., PhD, Mette Oestergaard, M.Sci., PhD, Morten T Andersen, M.Sci., Jelena V Jovanovic, Veli Kairisto, M.D., PhD, Jan K Larsen, MM.Sci., Yvonne G Morgan, Dr., Ugur Ozbek, M.D., PhD, Prof., Niels Pallisgaard, M.Sci., Heike Pfeifer, M.D., David Grimwade, PhD, FRCPath, Peter Hokland, M.D., D., Med., Sci.

Blood (2009) 114 (22): 1619.

https://doi.org/10.1182/blood.V114.22.1619.1619

Published: 2009

Journal Articles

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

J. D. Cavenagh, MD, MRCP, K. Yong, J. Byrne, J. Cavet, P. Johnson, G. Morgan, C. Williams, S. Akinaga, G. Francis, J. Kilborn

Blood (2008) 112 (11): 2777.

https://doi.org/10.1182/blood.V112.11.2777.2777

Published: 2008

Journal Articles

A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.

B. Lowenberg, MD, F. Davies, MD, C. Müller-Tidow, MD, Ulrich Dührsen, A. Burnett, MD, FRCP, P. Zachée, MD, PhD, D. Dierickx, MD, C. Jenkins, MD, P. Sonneveld, MD, M. Jongen-Lavrencic, MD, S. Zweegman, MD, G. Morgan, MD, U. Krug, MD, A. Richardson, PhD, L. Hooftman, MD, G. Ossenkoppele, MD, PhD

Blood (2008) 112 (11): 961.

https://doi.org/10.1182/blood.V112.11.961.961

Published: 2008

Journal Articles

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Blood (2005) 106 (11): 3414.

https://doi.org/10.1182/blood.V106.11.3414.3414

Published: 2005

Journal Articles

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

K. Tobal, J. Newton, M. Macheta, J. Chang, G. Morgenstern, P. A. S. Evans, G. Morgan, G. S. Lucas, J. A. Liu Yin

Blood (2000) 95 (3): 815–819.

https://doi.org/10.1182/blood.V95.3.815.003k30_815_819

Published: 2000

Journal Articles

Both Paroxysmal Nocturnal Hemoglobinuria (PNH) Type II Cells and PNH Type III Cells Can Arise From Different Point Mutations Involving the Same Codon of the PIG-A Gene

S. Rollinson, S. Richards, D. Norfolk, K. Bibi, G. Morgan, P. Hillmen

Blood (1997) 89 (8): 3069.

https://doi.org/10.1182/blood.V89.8.3069

Published: 1997

Journal Articles

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15

DJ Matthews, PA Clark, J Herbert, G Morgan, RJ Armitage, C Kinnon, A Minty, KH Grabstein, D Caput, P Ferrara

Blood (1995) 85 (1): 38–42.

https://doi.org/10.1182/blood.V85.1.38.bloodjournal85138

Published: 1995

NARROW

The Fetal Specific Gene LIN28B Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia

The IRF2BP2-RARα Fusion Generated By a Cryptic Rearrangement Transforms Hematopoietic Stem/Progenitor Cells and Induces Retinoid Sensitive Acute Promyelocytic Leukemia (APL)

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

Both Paroxysmal Nocturnal Hemoglobinuria (PNH) Type II Cells and PNH Type III Cells Can Arise From Different Point Mutations Involving the Same Codon of the PIG-A Gene

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only